Greece has many pharma companies and manufacturers, but the most prominent ones in the country are the ones that make the drugs that have made it to market, including the country’s pharmaceutical manufacturing license.
There’s a reason that the country has one of the lowest prices in Europe, with annual inflation averaging just 2 percent.
The number of companies in the Greek pharmaceutical industry has tripled in the past decade, and many are working on a wide range of products, including pharmaceuticals for human use, arthritis, cancer, and even a new generation of vaccines.
But even with this massive expansion in the industry, there’s still plenty of room for improvement.
The new drug patents, for example, were designed to allow the drug makers to control their own prices.
But the lack of an efficient system for managing supply chains, and the inability of the country to properly regulate them, have created a problem.
The drug manufacturers have had to make many deals to keep prices down, and there are many companies that have gone bankrupt.
But what makes the problem even worse is that the companies that make these drugs have no incentive to reduce their prices.
And because of this, the drug companies, as well as their competitors, are charging sky-high prices.
In fact, the government has recently decided to close down some drug companies for lack of money.
It’s not just the drug manufacturers that are being gouged by the government, either.
As part of the new tax, the tax will also raise money for a wide variety of other government programs, including education, the health system, and pensions.
This is all a bit of a joke, of course, and we should probably not get too caught up in it.
But this isn’t the first time Greece has tried to make money off its medicine industry.
During the 1980s, the country was also one of Europe’s most-sheltered, most-industrialized economies.
The country had a massive pharmaceutical industry, with more than 40 pharmaceutical manufacturing companies, many of which were also exporting their products to other countries.
These days, the number of Greek pharmaceutical manufacturing licenses is almost nonexistent, and only about 20 percent of all pharmaceutical manufacturing firms are still active.
That means that even if the government wanted to raise money to support other government functions, it would be almost impossible.